MIT Washington Seminar Series

Maggiano’s Little Italy Restaurant 5333 Wisconsin Avenue, NW, Washington, DC, United States

Julie Lenzer, Chief Innovation Officer at ARMI will present the Opportunities and Challenges of Manufacturing Human Cells, Tissues and Organs. Curing chronic disease and repairing traumatic injuries with engineered cells, cell therapies, tissues, and organs is the next frontier of medicine. This session will provide an overview of the promise of therapies currently in development […]

3D BIOPRINTING OPEN-SOURCE WORKSHOP @ Carnegie Mellon University

Carnegie Mellon University, Pittsburgh, PA 5000 Forbes Ave, Pittsburgh, PA, United States

This 3-day hands-on workshop will introduce individuals and teams to 3D printing of soft and biological materials; facilitate the assembly, operation and validation of an open source 3D bioprinting platform; and connect participants to a growing network of researchers working to advance 3D printing of soft and biological materials. Program and Schedule The program includes […]

$3000

Leadership Advisory Council Elections

Online Voting

The Leadership Advisory Council provides industry expertise and strategic guidance to the stakeholder council. Members of the council are elected by BioFabUSA’s membership.

Advanced Therapies Week

Miami Convention Center 1901 Convention Center Drive, Miami Beach, FL, United States

Advanced Therapies Week brings the global advanced therapies community together for the most important week for doing business in advanced therapies. Home to the largest marketplace for tools and tech, Advanced Therapies Week is dedicated to helping biotech progress on their commercialization journey, as well as pushing the industry one step closer to delivering life-changing […]

BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.

Technology

ARMI

Initiatives

Learn more about work underway to build the biofabrication ecosystem and accelerate the science of regenerative medicine.